Aralez Pharmaceuticals Insiders

Aralez Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (6.75) % which means that it has lost $6.75 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (262.08) %, meaning that it created substantial loss on money invested by shareholders. Aralez Pharmaceuticals' management efficiency ratios could be used to measure how well Aralez Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. The company has Profit Margin (PM) of (99.5) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (45.33) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $45.33.

Aralez Pharmaceuticals Notable Stakeholders

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

If you are still planning to invest in Aralez Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aralez Pharmaceuticals' history and understand the potential risks before investing.